🇺🇸 R2-Total targeted treatment with azithromycin in United States

R2-Total targeted treatment with azithromycin (R2-Total targeted treatment with azithromycin) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

R2-Total targeted treatment with azithromycin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is R2-Total targeted treatment with azithromycin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for R2-Total targeted treatment with azithromycin in United States?

Lihir Medical Centre is the originator. The local marketing authorisation holder may differ — check the official source linked above.